Skip to main content
All blogsResearch

Where to Inject Semaglutide and Tirzepatide

Both are once-weekly subcutaneous injections, and the three standard sites are the same for each. The part that trips people up is not the site. It is that a compounded vial is not a prefilled pen, so you are drawing your own dose and reading it in syringe units. Here is the practical version.

PeRx PeptidesReviewed by Dr. Cory Mellon, MD12 min readPublished
A compounded vial is not a prefilled pen.
A compounded vial is not a prefilled pen.

Key Takeaways

  • Both semaglutide and tirzepatide are subcutaneous injections, not intramuscular. The needle goes into the fat layer just under the skin, and the three approved sites are the abdomen, the front or outer thigh, and the back of the upper arm.
  • Site choice does not meaningfully change how the medication works. Absorption from all three sites is close enough that the labeling for the approved products lets patients switch between them without a dose change. Pick the site you can reach comfortably and reliably.
  • Rotate anyway. Repeatedly injecting the same square inch causes lipohypertrophy, a firm fatty lump that absorbs erratically. Rotation is about protecting the tissue, not about chasing a better effect.
  • The real difference between a compounded vial and a brand-name pen is measurement. A pen dials a fixed dose. A vial means you draw the dose yourself and read it in syringe units, which is where the reported dosing errors come from.
  • Never convert your own dose. The number of units you draw depends on the concentration of your specific vial, so it comes from your prescription label, not from a chart you found online.
  • These are prescription medications compounded by a licensed pharmacy for an individual patient. They are not the FDA-approved products, and they have not been through the FDA approval process themselves.

The Three Sites

Semaglutide and tirzepatide are both given as a subcutaneous injection once a week. Subcutaneous means the medication goes into the layer of fat between the skin and the muscle, not into the muscle itself. That layer is shallow, which is why the needles are short and thin and why most people find the injection far less dramatic than they expected.

There are three standard sites, and they are the same for both medications:

Abdomen

Where exactly
Anywhere across the belly, staying at least two inches away from the navel
Practical notes
The most used site. Easy to see, easy to reach, usually the most generous fat layer. Avoid the waistband line if your clothes press there all day.

Thigh

Where exactly
The front or outer thigh, roughly the middle third between hip and knee
Practical notes
Easy to reach sitting down. Skip the inner thigh, where the tissue is thinner and more sensitive.

Upper arm

Where exactly
The back of the upper arm, over the triceps
Practical notes
Works well but is awkward to do on yourself. Most people who use this site have someone else do it.

One rule that covers all three

Inject into soft tissue you can pinch. Skip anywhere that is bruised, tender, red, hard, scarred, or tattooed over raised ink, and stay clear of the navel. If a spot feels lumpy compared to the skin around it, use somewhere else and mention it at your next visit.

Does the Site Actually Matter?

Less than people expect. The instructions for use on the FDA-approved semaglutide and tirzepatide products list the abdomen, thigh, and upper arm as interchangeable, and they do not ask patients to change the dose when switching between them. Absorption differs slightly between sites in the way it does for most subcutaneous drugs, but not by enough to build a strategy around.

This matters because the internet is full of confident claims that one site produces better results, fewer side effects, or faster onset. There is no good evidence for that with these medications. The site that works best is the one you can reach without contorting, see clearly, and use consistently week after week. Consistency beats optimization here, because the failure mode that actually costs people progress is a missed or badly measured dose, not a suboptimal square inch of skin.

Rotation and Why It Matters

Rotating sites is not about improving absorption. It is about not wearing out one patch of tissue. Injecting the same spot repeatedly can cause lipohypertrophy, a firm rubbery thickening of the fat under the skin. It is the same problem people who inject insulin have known about for decades. Once it forms, that tissue absorbs unpredictably, which means the dose you measured is not necessarily the dose you get.

With a weekly injection you have a lot of room to work with. A simple approach that people actually stick to: pick one site for the month and move about an inch each week within it, then switch sites the next month. Or rotate quadrants of the abdomen, one per week. Either works. The only thing that does not work is using the same spot every Sunday for a year.

A trick that removes the guesswork

Write the date and the spot on the same note where you log the dose. Most people cannot remember on Sunday where they injected the previous Sunday, and a two-word log ends the problem permanently. If you would rather not keep notes, tie the site to something fixed: left side on even weeks, right side on odd.

The Vial Is Not a Pen

This is the part most guides skip, and it is the part that matters most if you are moving from a brand-name product to a compounded one.

The FDA-approved products, Ozempic and Wegovy for semaglutide and Mounjaro and Zepbound for tirzepatide, are supplied as prefilled pens or single-dose devices. The dose is set by the device. You do not measure anything. A compounded product is different: it is a vial, and you draw your dose out of it with a syringe. Nothing about the medication is harder to inject, but the measurement step is now yours, and that is a genuinely new task if a pen is all you have used.

Why this deserves real attention

The FDA has received reports of dosing errors involving compounded GLP-1 medications, including cases where patients drew far more than intended because they confused the units on the syringe with the milligrams on the prescription. This is not a reason to avoid a vial. It is a reason to read your own label carefully the first time and to ask rather than guess.

Units, and the Mistake to Avoid

Your prescription is written in milligrams. Your syringe is marked in units. Those are not the same thing, and the number that connects them depends on how concentrated your particular vial is. Two vials of the same medication at different concentrations require completely different volumes for the identical dose.

So the safe rule is short: the number of units you draw comes from your prescription label and your prescriber, not from a conversion chart online. A chart written for someone else’s concentration will give you the wrong answer with total confidence. If your label and your understanding disagree, stop and ask before you draw.

What to check before the first dose

Confirm three things on the label: the concentration of the vial, the dose you are prescribed, and the number of units that corresponds to. If any of the three is unclear, that is a question for the pharmacy or your provider, and it is a completely ordinary thing to ask about. Nobody expects a patient to do pharmacy math.

One more reason to re-read the label rather than working from memory: these medications are titrated. Prescribing usually starts low and steps up over months, so the strength your provider sets is a clinical decision made fresh each cycle rather than a number that stays fixed. At PeRx, semaglutide and tirzepatide ship one vial per 28-day cycle, which is exactly four weekly doses, and the provider re-sets the strength at each renewal rather than the patient choosing it at checkout. The practical consequence is simple. When a new vial arrives, check the label again. The units you drew last cycle are not automatically the units you draw this one.

The Injection Itself

The mechanics are the same as any subcutaneous injection, and they are genuinely simple once you have done one.

Wash your hands. Wipe the vial stopper and the skin with an alcohol swab and let both dry, because injecting through wet alcohol stings. Draw your dose. Pinch a fold of skin, insert the needle at somewhere between 45 and 90 degrees depending on how much tissue you have, push the plunger steadily, and pull straight out. Dispose of the syringe in a sharps container, not a household bin.

You do not need to aspirate, which is the step where you pull back on the plunger to check for blood. That is an intramuscular practice and it is not part of subcutaneous technique. If a small bead of blood appears afterward, press it with a clean cotton pad rather than rubbing, and carry on.

Making It Hurt Less

Most of the discomfort people report has a fixable cause. Cold medication straight from the refrigerator stings more than medication that has sat out for a few minutes, so letting the drawn syringe come toward room temperature usually helps. Wet alcohol stings, so let the swab dry. A dull needle stings, so use a new one every time rather than re-capping and reusing.

Going slowly on the plunger reduces the pressure sensation, and relaxing the muscle underneath matters more than people expect. Injecting into a tensed thigh is noticeably worse than injecting into a relaxed one. If a particular site is consistently uncomfortable no matter what you do, that is useful information: use a different one.

Timing and the Weekly Rhythm

Both medications are dosed once weekly, and neither depends on food. You can inject at any time of day, with or without a meal. What matters is picking a day and staying with it, because the weekly rhythm is what keeps levels steady.

A practical consideration people figure out the hard way: if side effects show up for you, they tend to be most noticeable in the first day or two after a dose. Some people therefore prefer to inject on a day when the following morning is quiet rather than the morning of something demanding. That is a scheduling preference, not a medical rule, and your provider sets the actual protocol.

PeRx ships compounded medications fully reconstituted and ready to use, stored refrigerated at 36 to 46 degrees Fahrenheit. There is nothing to mix. The same storage logic that applies to the rest of the catalog applies here, and the traveling with peptides guide covers keeping a vial cold on the road.

When Something Looks Wrong

A small amount of redness, a little swelling, or mild itching at the injection site is common and usually settles within a day. Persistent hardness under the skin, a lump that does not resolve, spreading redness, warmth, or anything that looks like an infection is a reason to contact a clinician rather than to keep injecting the same area. If lumps, bruising, or lingering soreness are the recurring problem rather than a one-off, injection site irritation on a GLP-1 covers why the tissue reacts and what actually helps.

Inspect the vial every time

The solution should be clear and colorless, or the expected color for your specific formulation, and free of particles. If it looks cloudy, has visible specks, or has changed appearance from when it arrived, do not use it. Contact the pharmacy. Do not use a vial that has been frozen, and do not use one past the beyond-use date on the label.

Common Questions

The abdomen, at least two inches from the navel, is the most commonly used site because it is easy to see and reach and usually has a comfortable fat layer. The front or outer thigh and the back of the upper arm are equally valid. The instructions for use on the approved products treat these three as interchangeable and do not require a dose change when you switch, so choose based on what you can do reliably rather than on any claimed advantage.

No. Tirzepatide uses the same three subcutaneous sites as semaglutide: abdomen, thigh, and back of the upper arm. The technique is identical. The dose and the concentration differ, so the number of units you draw is specific to your own prescription.

There is no good evidence that it does for these medications. Absorption varies slightly between subcutaneous sites, as it does with most injectables, but not by an amount that changes the outcome or the dose. Claims that one site produces faster results or fewer side effects are not supported. Pick the site you will use consistently.

Move to a different spot every week. You do not have to change sites entirely, just move roughly an inch within the same area, or rotate through quadrants of the abdomen. The purpose is preventing lipohypertrophy, a firm thickening of the fat that develops when one spot is used repeatedly and that causes erratic absorption once it forms.

Prefilled pens are the delivery format of the FDA-approved products. A compounded medication is prepared by a licensed pharmacy against an individual prescription and is supplied in a vial, so you draw the dose with a syringe. The medication is injected the same way. The difference is that measuring the dose is now a step you perform, which is why the label and the unit count matter more than they do with a pen.

That number comes from your prescription label, because it depends on the concentration of your specific vial. The same dose in milligrams corresponds to different volumes at different concentrations, so a conversion chart written for someone else can be badly wrong. If the label is not clear, ask the pharmacy or your provider before drawing anything.

No. Pulling back on the plunger to check for blood is an intramuscular injection practice and is not part of subcutaneous technique. If you see a small bead of blood after withdrawing the needle, apply gentle pressure with a clean pad rather than rubbing.

Any time. Neither medication depends on food or time of day, and both are dosed once weekly. Choose a day you will remember and keep it consistent. Some people prefer a day when the next morning is unhurried, since side effects, when they occur, tend to be most noticeable in the first day or two after a dose.

Do not double up to catch up, and do not improvise a schedule change. What to do depends on how long it has been and on your specific protocol, so this is a question for your provider rather than one to solve from a forum post.

No, and the distinction matters. Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved products manufactured by their sponsors. A compounded medication is prepared by a licensed compounding pharmacy for an individual patient under a prescription, and it has not itself been through FDA review for safety or effectiveness. Studies conducted on the approved products are studies of those products, not of a compounded preparation. Discuss which pathway is appropriate for you with a licensed provider.

Avoid scarred tissue and raised or freshly healed tattoo work, since both absorb unpredictably. Flat, fully healed tattooed skin is generally acceptable, though many people simply choose an untattooed area to keep things straightforward.

They go in a sharps container, not a household bin. Most pharmacies sell approved containers inexpensively, and disposal rules vary by state, so check your local guidance for how to return or discard a full one.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to get started?

Pharmaceutical-grade peptides, prescribed by a licensed provider and shipped fully reconstituted and ready to use. Browse the catalog to read about what each one does, or start with the primer on [what peptide therapy is](/blog/what-is-peptide-therapy).

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.